These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
433 related articles for article (PubMed ID: 7511188)
21. Increased levels of glycoproteins containing mannose 6-phosphate in human breast carcinomas. Sleat DE; Chen TL; Raska K; Lobel P Cancer Res; 1995 Aug; 55(15):3424-30. PubMed ID: 7614483 [TBL] [Abstract][Full Text] [Related]
22. The localization of the insulin-like growth factor receptor 1 (IGFR-1) in benign and malignant breast tissue. Happerfield LC; Miles DW; Barnes DM; Thomsen LL; Smith P; Hanby A J Pathol; 1997 Dec; 183(4):412-7. PubMed ID: 9496257 [TBL] [Abstract][Full Text] [Related]
23. Loss of the tight junction protein claudin-7 correlates with histological grade in both ductal carcinoma in situ and invasive ductal carcinoma of the breast. Kominsky SL; Argani P; Korz D; Evron E; Raman V; Garrett E; Rein A; Sauter G; Kallioniemi OP; Sukumar S Oncogene; 2003 Apr; 22(13):2021-33. PubMed ID: 12673207 [TBL] [Abstract][Full Text] [Related]
24. Thrombospondins, metallo proteases and thrombospondin receptors messenger RNA and protein expression in different tumour sublines of the Dunning prostate cancer model. Vallbo C; Damber JE Acta Oncol; 2005; 44(3):293-8. PubMed ID: 16076702 [TBL] [Abstract][Full Text] [Related]
25. Thrombospondin-1 and -2 messenger RNA expression in normal, benign, and neoplastic human breast tissues: correlation with prognostic factors, tumor angiogenesis, and fibroblastic desmoplasia. Bertin N; Clezardin P; Kubiak R; Frappart L Cancer Res; 1997 Feb; 57(3):396-9. PubMed ID: 9012463 [TBL] [Abstract][Full Text] [Related]
26. Differential loss of E-cadherin expression in infiltrating ductal and lobular breast carcinomas. Moll R; Mitze M; Frixen UH; Birchmeier W Am J Pathol; 1993 Dec; 143(6):1731-42. PubMed ID: 8256859 [TBL] [Abstract][Full Text] [Related]
27. Immunohistochemical localization of metallothionein in human breast cancer in comparison with cathepsin D, stromelysin-1, CD44, extracellular matrix components, P53, Rb, C-erbB-2, EGFR, steroid receptor content and proliferation. Ioachim E; Kamina S; Demou A; Kontostolis M; Lolis D; Agnantis NJ Anticancer Res; 1999; 19(3A):2133-9. PubMed ID: 10470161 [TBL] [Abstract][Full Text] [Related]
28. Thrombospondin modulates human breast adenocarcinoma cell adhesion to human vascular endothelial cells. Incardona F; Lewalle JM; Morandi V; Lambert S; Legrand Y; Foidart JM; Legrand C Cancer Res; 1995 Jan; 55(1):166-73. PubMed ID: 7805029 [TBL] [Abstract][Full Text] [Related]
29. Tissue distribution of major matrix metalloproteinases and their transcripts in human breast carcinomas. Lebeau A; Nerlich AG; Sauer U; Lichtinghagen R; Löhrs U Anticancer Res; 1999; 19(5B):4257-64. PubMed ID: 10628384 [TBL] [Abstract][Full Text] [Related]
30. TRAIL death receptor-4 expression positively correlates with the tumor grade in breast cancer patients with invasive ductal carcinoma. Sanlioglu AD; Korcum AF; Pestereli E; Erdogan G; Karaveli S; Savas B; Griffith TS; Sanlioglu S Int J Radiat Oncol Biol Phys; 2007 Nov; 69(3):716-23. PubMed ID: 17512128 [TBL] [Abstract][Full Text] [Related]
31. Integrin expression on normal and neoplastic human breast epithelium. Damjanovich L; Fülöp B; Adány R; Nemes Z Acta Chir Hung; 1997; 36(1-4):69-71. PubMed ID: 9408292 [TBL] [Abstract][Full Text] [Related]
32. Differential distribution of tenascin in the normal, hyperplastic, and neoplastic breast. Howeedy AA; Virtanen I; Laitinen L; Gould NS; Koukoulis GK; Gould VE Lab Invest; 1990 Dec; 63(6):798-806. PubMed ID: 1701508 [TBL] [Abstract][Full Text] [Related]
33. Coexpression of hepatocyte growth factor and receptor (Met) in human breast carcinoma. Tuck AB; Park M; Sterns EE; Boag A; Elliott BE Am J Pathol; 1996 Jan; 148(1):225-32. PubMed ID: 8546209 [TBL] [Abstract][Full Text] [Related]
34. Keratin 19 in paraffin sections of medullary carcinoma and other benign and malignant breast lesions. Dalal P; Shousha S Mod Pathol; 1995 May; 8(4):413-6. PubMed ID: 7567941 [TBL] [Abstract][Full Text] [Related]
35. Seprase, a membrane-bound protease, is overexpressed by invasive ductal carcinoma cells of human breast cancers. Kelly T; Kechelava S; Rozypal TL; West KW; Korourian S Mod Pathol; 1998 Sep; 11(9):855-63. PubMed ID: 9758365 [TBL] [Abstract][Full Text] [Related]
36. Clinicopathological study of the expression of syndecan-1 in invasive breast carcinomas. correlation with extracellular matrix components. Tsanou E; Ioachim E; Briasoulis E; Charchanti A; Damala K; Karavasilis V; Pavlidis N; Agnantis NJ J Exp Clin Cancer Res; 2004 Dec; 23(4):641-50. PubMed ID: 15743035 [TBL] [Abstract][Full Text] [Related]
37. The urokinase receptor is expressed in invasive breast cancer but not in normal breast tissue. Bianchi E; Cohen RL; Thor AT; Todd RF; Mizukami IF; Lawrence DA; Ljung BM; Shuman MA; Smith HS Cancer Res; 1994 Feb; 54(4):861-6. PubMed ID: 8313371 [TBL] [Abstract][Full Text] [Related]
38. Computer-assisted image analysis of tumor sections for a new thrombospondin receptor. Arnoletti JP; Albo D; Jhala N; Granick MS; Solomon MP; Atkinson B; Rothman VL; Tuszynski GP Am J Surg; 1994 Nov; 168(5):433-6. PubMed ID: 7526719 [TBL] [Abstract][Full Text] [Related]
39. Elevated osteopontin and thrombospondin expression identifies malignant human breast carcinoma but is not indicative of metastatic status. Wang-Rodriguez J; Urquidi V; Rivard A; Goodison S Breast Cancer Res; 2003; 5(5):R136-43. PubMed ID: 12927044 [TBL] [Abstract][Full Text] [Related]
40. Expression of c-kit proto-oncogene product in breast tissue. Yared MA; Middleton LP; Meric F; Cristofanilli M; Sahin AA Breast J; 2004; 10(4):323-7. PubMed ID: 15239791 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]